CPRX
Catalyst Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.49
+0.00%Margins
Gross margin
82.3%
EBITDA margin
56.1%
EBIT margin
44.8%
Net margin
37.1%
FCF margin
34.9%
21.9%
Return on equity
19.3%
Return on assets
26.4%
Return on invested capital
0.53x
Asset turnover
$208.2M
Cash from operations
$6.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026